FDA Seeks Public Input Relating to Regulatory Considerations for Generative AI –Enabled ...
... risk assessment, premarket evaluation, and postmarket monitoring. “ Artificial intelligence is transforming medicine, and the United States must ...
Read the original at ascopost.com ↗
- Topics
- Regulation & PolicyHealthcareChatbots & LLMsMarkets & Investment
- Mentions
- FDAUnited States
- Tracked via
- “AI Risks”